Stay updated on Bedaquiline and Delamanid Combo in DR-TB Clinical Trial
Sign up to get notified when there's something new on the Bedaquiline and Delamanid Combo in DR-TB Clinical Trial page.

Latest updates to the Bedaquiline and Delamanid Combo in DR-TB Clinical Trial page
- Check4 days agoChange DetectedAdded: Show glossary, Last Update Submitted that Met QC Criteria, No FEAR Act Data, and Revision: v3.4.0; Deleted: Last Update Submitted that met QC Criteria, No FEAR Act data, and Revision: v3.3.4.SummaryDifference0.2%

- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedA minor page revision changed from v3.3.3 to v3.3.4; no substantive changes to the study details, eligibility criteria, or locations are evident. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check40 days agoChange DetectedAdded a Locations section with Western Cape entries and updated the page revision to v3.3.3, removing the prior Western Cape Locations and HHS Vulnerability Disclosure references (v3.3.2).SummaryDifference0.2%

- Check69 days agoChange DetectedPublications section now states that publications are automatically filled from PubMed and may not be about the study. The revision tag changed from v3.2.0 to v3.3.2.SummaryDifference0.1%

- Check76 days agoChange DetectedThe general government funding/operating status notice was removed; study details, contacts, and eligibility criteria remain accessible.SummaryDifference0.3%

- Check97 days agoChange DetectedOnly minor UI refinements and small text/date updates were observed on the Study Details page, with no substantive changes to core study content, and to avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

Stay in the know with updates to Bedaquiline and Delamanid Combo in DR-TB Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Bedaquiline and Delamanid Combo in DR-TB Clinical Trial page.